L&C Bio Co., Ltd (290650.KQ)
KRW 22450.0
(-1.54%)
KRW 22450.0
(-1.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 67.18 Billion KRW | -10.84% |
| 2022 | 75.35 Billion KRW | 814.18% |
| 2021 | -10.55 Billion KRW | -45.87% |
| 2020 | -7.23 Billion KRW | 34.09% |
| 2019 | -10.97 Billion KRW | 46.78% |
| 2018 | -20.62 Billion KRW | -676.41% |
| 2017 | -2.65 Billion KRW | -574.15% |
| 2016 | 560.17 Million KRW | -55.64% |
| 2015 | 1.26 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 73.26 Billion KRW | 3.4% |
| 2024 Q1 | 70.85 Billion KRW | 5.46% |
| 2023 Q2 | 81.27 Billion KRW | 8.65% |
| 2023 Q4 | 67.18 Billion KRW | 0.83% |
| 2023 FY | 67.18 Billion KRW | -10.84% |
| 2023 Q1 | 74.8 Billion KRW | -0.72% |
| 2023 Q3 | 66.63 Billion KRW | -18.02% |
| 2022 FY | 75.35 Billion KRW | 814.18% |
| 2022 Q4 | 75.35 Billion KRW | 14.95% |
| 2022 Q3 | 65.55 Billion KRW | 51.71% |
| 2022 Q2 | 43.21 Billion KRW | 9264.49% |
| 2022 Q1 | -471.5 Million KRW | 95.53% |
| 2021 Q1 | -3.92 Billion KRW | 45.74% |
| 2021 Q4 | -10.55 Billion KRW | 4.71% |
| 2021 Q3 | -11.07 Billion KRW | 21.22% |
| 2021 Q2 | -14.05 Billion KRW | -258.12% |
| 2021 FY | -10.55 Billion KRW | -45.87% |
| 2020 FY | -7.23 Billion KRW | 34.09% |
| 2020 Q3 | -7.3 Billion KRW | -90.53% |
| 2020 Q4 | -7.23 Billion KRW | 0.96% |
| 2020 Q2 | -3.83 Billion KRW | 71.44% |
| 2020 Q1 | -13.41 Billion KRW | -22.28% |
| 2019 Q3 | -13.63 Billion KRW | -0.03% |
| 2019 Q4 | -10.97 Billion KRW | 19.5% |
| 2019 FY | -10.97 Billion KRW | 46.78% |
| 2019 Q2 | -13.62 Billion KRW | 31.59% |
| 2019 Q1 | -19.92 Billion KRW | 3.39% |
| 2018 Q2 | -2.45 Billion KRW | 0.0% |
| 2018 FY | -20.62 Billion KRW | -676.41% |
| 2018 Q4 | -20.62 Billion KRW | 0.0% |
| 2017 Q4 | -2.65 Billion KRW | 0.0% |
| 2017 FY | -2.65 Billion KRW | -574.15% |
| 2016 FY | 560.17 Million KRW | -55.64% |
| 2015 FY | 1.26 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | -108.91 Billion KRW | 161.684% |
| InBody Co.,Ltd | -16.2 Billion KRW | 514.576% |
| Curexo Inc. | -15.03 Billion KRW | 546.929% |
| Seegene, Inc. | -48.57 Billion KRW | 238.306% |
| i-SENS, Inc. | 98.45 Billion KRW | 31.762% |
| Ray Co., Ltd. | 67.09 Billion KRW | -0.134% |
| Gencurix Inc. | 15.02 Billion KRW | -347.147% |
| Sugentech Inc. | -6.95 Billion KRW | 1066.484% |